Abeome to Present New Data on IL-25 Asthma Program at Keystone Asthma: From Pathway Biology to Precision Therapeutics
Athens, Georgia, February 3, 2017 – Abeome Corporation will present 2 posters at Keystone February 13-16, 2017 describing significant advancements in its IL-25 asthma program.